What are viral titer assays?
Viral titer assays are designed to quantify viral vector concentration. In addition to cell and gene therapy gene transfer workflows, viral titer assays are integral to the study of infectious disease pathogenesis and vaccine development. At a high level, viral titer assays quantify: DNA titer, infectious titer, or capsid titer. DNA titer assays quantify the number of viral capsids containing DNA. Infectious titer assays quantify infectious particles that transfer DNA into host cells via a process called viral transduction. Capsid titer assays quantify viral capsids. Capsids may or may not contain viral DNA.
Learn more about viral titer assays at our Partner PROGEN’s website
What type of viral titer assay is the Simple Plex Immunoassay?
Simple Plex automated viral titer assays quantify viral particles, also known as capsids.
Learn more about Simple Plex Assays and the Ella Platform
I am looking for automated and scalable solutions for cell and gene therapy research and manufacturing. What do you suggest?
ProteinSimple, a Bio-techne Brand has several analytical solutions to suit your cell and gene therapy research and development needs. Download our eBook to see real-world examples of time, cost, and sample savings from our analytical solutions.
Download the Next Generation Analytical Solutions for Cell and Gene Therapy eBook
Do you have any other resources for cell and gene therapy research and manufacturing?
Bio-Techne spans the cell and gene therapy workflow. Solutions are available for immune cell therapy and regenerative medicine. Gene engineering services are also available using our nonviral TC BusterTM gene delivery system. GMP-grade raw materials and services are also available.
Find out more about our solutions for cell and gene therapy research and manufacturing, at Bio-Techne.com